ABUS vs MDT · P/E 5.4, rev $6.2M vs P/E 21, rev $36.36B
Arbutus Biopharma Corp (ABUS) versus Medtronic PLC (MDT) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Medtronic PLC (MDT) is a medical devices company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Not investment advice. Open the ABUS and MDT stock pages for the full models.
Not investment advice.